Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alaska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alaska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alaska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Colleen Kersgard (NPI 1194875831)

Field	Value
Entity Type	Individual
Organization	Colleen Kersgard
Address	2490 S Woodworth Loop Ste 499
City	Palmer
State	AK
ZIP	99645
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	January 12, 2007

Payer Source	Total Paid
Medicare	$944.9K
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the sole visible payer activity: lifetime Medicare revenue is $944.9K and there is no Medicaid billing on file. That makes the practice effectively single-payer (Medicare) in the available claims data, which concentrates reimbursement exposure to federal fee schedules and Medicare beneficiary populations.

Revenue is highly concentrated: the precomputed top 3 Medicare codes by revenue account for 86.5% of this provider’s total Medicare revenue. Those top drivers are J9271 (55.0% of provider Medicare revenue, 12K claims, $516K revenue), J0897 (20.5% of provider Medicare revenue, 10.7K claims, $192.2K revenue), and 99214 (11.0% of provider Medicare revenue, 826 claims, $103.3K revenue), indicating a very small set of services produce the bulk of income.

Clinical/service-line profile aligns with an office-based oncology infusion practice: dominant use of J9271 (pembrolizumab) and J0897 (denosumab) points to regular administration of high-volume biologic therapies and bone-targeted treatments delivered via infusion or injection. The presence of 99214 with substantial revenue ($103.3K, 826 claims) further indicates ongoing outpatient management and follow-up visits typical of a hematology & oncology physician.

Competitive standing varies by code. For the top drug J9271 the provider ranks #952 of 1841 nationally (48th percentile) — a middle-of-pack national participant for pembrolizumab; for J0897 the provider ranks #1027 of 10057 (90th percentile), indicating relatively high national volume for denosumab compared with peers; and for 99214 the provider ranks #18172 of 479517 (96th percentile), described in the source as "notably above typical," showing above-average E/M visit volume relative to national peers.

Operational mix shows an infusion-heavy practice with supportive and administration services: chemotherapy administration 96413 appears with 276 claims and $32.3K revenue (3.4% of Medicare revenue), and add-on infusion codes such as 96417 (135 claims, $8K) and 96415 (90 claims, $2.3K) are present, indicating routine multi-drug and multi-hour infusion workflows rather than isolated procedural or diagnostic billing. Multiple low-dollar pharmacy/support codes (for example, J2469 990 claims, $990 revenue and numerous lab/venipuncture codes such as 85025 with 797 claims, $8K) reflect ancillary services that support an infusion clinic model.

Volume counts underscore throughput: very high claim volumes for key injectable drugs (12K claims for J9271 and 10.7K claims for J0897) combined with hundreds of E/M and administration claims suggest sustained, recurrent patient visits and regular infusion sessions rather than one-off procedures. This operational cadence is consistent with chronic oncology treatment regimens and ongoing disease management.

Provider tenure is long-standing: NPI enumerated on 2007-01-12 (~19 years ago), indicating nearly two decades of billing history under this identifier, which supports interpretation of established practice patterns rather than a short-term anomaly.

Payer-concentration implications for contracting and care management are material: with $944.9K in Medicare revenue and no Medicaid billing on file, the practice’s revenue and exposure are concentrated in Medicare; payers and network managers should treat this entity as Medicare-centric when evaluating reimbursement, utilization management, and quality measurement alignment.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

33 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	12,000	$40	$516K
J0897	Injection, denosumab, 1 mg	10,680	$20	$192.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	830	$130	$103.3K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	280	$120	$32.3K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	110	$160	$18.5K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	800	$10	$8K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	140	$60	$8K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	940	$10	$7.5K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	120	$60	$7.1K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	250	$30	$6.8K

Showing 1–10 of 33

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 33 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alaska Distribution

Colleen Kersgard — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alaska

Full comparison — all codes billed, vs. state median

33 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	8	10	13,300	$40	$609.5K
J0897	3	30	2,700	$20	$82.7K
96413	10	20	230	$110	$30.2K
99214	17	1,210	90	$100	$16.2K
99215	302	400	40	$150	$11K
99205	92	140	30	$190	$7.4K
99204	32	460	30	$140	$6.1K
96417	5	20	100	$60	$5.3K
96365	10	30	70	$50	$4.8K
96367	3	20	180	$20	$4.4K

Showing 1–10 of 33

Related Providers

Other providers that share a Tax Identification Number (TIN) with Colleen Kersgard, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Lawrence Lawson	AK	Medical Oncology Physician	$779K	$0
Midnight Sun Oncology Partners, LLC	AK	Hematology & Oncology Physician	$0	$648.3K

Nearby Providers

Other providers in the same ZIP code as Colleen Kersgard, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mat-su Valley Medical Center LLC	AK	General Acute Care Hospital	$0	$67.4M
Mat-su Emergency Medicine Physicians Corp	AK	Emergency Medicine Physician	$0	$14.3M
Co Occuring Disorders Institute	AK	Community/Behavioral Health Agency	$0	$7.3M
Division Of Alaskan Pioneer Homes	AK	Assisted Living Facility	$0	$6.1M
Matanuska-susitna Borough School District	AK	Local Education Agency (LEA)	$0	$6M
Matanuska Susitna Borough	AK	Land Ambulance	$1.2M	$4.2M
Ak Nurtured Living LLC	AK	Assisted Living Facility	$0	$5.4M
Knik Tribe	AK	Community/Behavioral Health Agency	$0	$3.8M
Daybreak Incorporated	AK	Case Management Agency	$0	$3.6M
City & Borough Of Juneau Alaska	AK	Land Ambulance	$580.5K	$2.4M

Colleen Kersgard — Billing Profile & Reimbursement Data

Sign up for Colleen Kersgard — Billing Profile & Reimbursement Data policy alerts

Colleen Kersgard — Billing Profile & Reimbursement Data

Sign up for Colleen Kersgard — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References